The transformation of the research and innovation achievements of Chinese medicine linked diseases helps the development of Chinese medicine towards a new era

On July 6, the Management Committee of Shijiazhuang High -tech Industrial Development Zone, Hebei Pharmaceutical Association, Hebei Provincial Pharmaceutical Industry Association, and World Chinese Medicine Association Joint Society of Medicine Corporation and other joint sponsored "The Summit Forum" and the Innovation Achievement Transformation Forum was held. Zhang Boyi, Cong Bin, Zhang Yun, Yang Baofeng, Yu Jinming, Tian Jinzhou, Wu Yiling and other academicians, as well as Li Yigui, a master of Chinese medicine, and well -known experts and scholars from the Chinese medicine industry from all over the country gathered through the way The important achievements of theoretical inheritance, innovation, and transformation have conducted in -depth exchanges.

Zhang Boli, an academician of the Chinese Academy of Engineering and the honorary title of the "People's Heroes" national honor, Zhan Peng, deputy mayor of Shijiazhuang City, Liu Xiaozhen, chairman of the Hebei Pharmaceutical Association, and Liu Xiaozhen, secretary of the Party Branch of the Hebei Medical Industry Association. The transformation of theoretical research and innovation results of the theoretical of neat disease has provided a useful reference to promote the construction of the Chinese medicine scientific and technological innovation system and the development of traditional Chinese medicine.

△ Academician Zhang Boli delivered a speech at the meeting.

Academician Zhang Boli pointed out that the theory of linked disease is an important achievement of modern Chinese medicine research and a model of inheritance and innovation of traditional Chinese medicine. The theoretical system system built by Academician Wu Yiling has clarified the diagnostic standards, scope of applications, and modern biological mechanisms. Under the guidance of the theoretical of the neat pathology, it has developed through the heart of the heart, ginseng pine, and osteophytes, and even the flowers clearing the plague. Waiting for Tongluo Drugs, a series of strict evidence -based medical evaluations were conducted at the same time, which achieved good results in the prevention and treatment of major clinical diseases. The holding of the study and innovation achievement of traditional Chinese medicine linked diseases is of great significance to how to better apply the theory of neat disease to major diseases to prevent and control the general public.

△ In the session of academicians, academicians exchanged exchanges on the transformation of the research and innovation achievements of Chinese medicine.

The system builds a theoretical system of neat disease to establish a new subject of traditional Chinese medicine linked diseases to promote the development of the industry

Inheritance, innovation and development of Chinese medicine is an important part of the cause of socialism with Chinese characteristics in the new era, and it is a major event for the great rejuvenation of the Chinese nation. List disease is one of the typical representatives of the essence of Chinese medicine inheritance and conservation of innovation. The theory of traditional Chinese medicine is the academic topic of Systematic research from Academician Wu Yiling in the 1970s. Through more than 40 years of hard work innovation, the "linked disease" has finally stretched the scattered record in the history of the Chinese national medicine. System theory of treatment value.

The "three -dimensional three -dimensional network system" framework is proposed to study the physiological function of the collateral vein and the onset of the vein, the pathogenesis, syndrome differentiation and treatment of the pathogenesis of the collaterals, and the first establishment of the "Cover Cover" system, establishing cardiovascular and cerebrovascular diseases, diabetes, diabetes And its complications, tumors, influenza and other ancients called the diseased disease method of Chinese medicine, which are called linked diseases, and published the monographs of the "List Diseases"; Effective new ways of microvascular lesions, publish the monograph on the theory of "Polaris"; systematically explain the occurrence of air lesions, development laws, basic pathological changes, clinical syndrome characteristics, and dialectical treatment of dialectic treatment, effectively guiding neurological, endocrine, immune diseases and other modern major diseases Treatment, publishing the monograph of Qi Liang. "List Diseases" has become an innovative textbook for colleges and universities in higher medicine in the new century, and has started courses in more than 40 universities at home and abroad. Singapore and American Medical Schools offer English courses in "List Diseases", and have established "Taiwan List Society", "Canadian Society", "European Society of Listing Diseases", "American Society of Listing diseases" and other domestic and foreign academic communication platforms. Essence

The "Listing theory and its application research" won the second prize of national scientific and technological progress. The "Chinese Medicine List Disease Diagnosis and Treatment Method" as the inheritance of Academician Wu Yiling was selected as a national intangible cultural heritage list.

The theoretical guidance of the new patent drug of the R & D patent, providing a more ideal choice for clinical treatment

In recent years, the development of traditional Chinese medicine has been highly valued by the Party Central Committee and the State Council. The breakthrough of theory is the transformation of Chinese medicine into productivity and the cornerstone of industrialization. Under the guidance of the theory of the neat disease, 13 innovative patent traditional Chinese medicines are developed. Products cover six major types of diseases with high incidence of cardiovascular and cerebrovascular disease, diabetes, respiratory diseases, tumors, neuropathy, and urinary system diseases. A number of effective drugs such as capsule, ginseng Yangxin capsule capsules, Qiqiang Qiangxin capsules, Lianhua Qingjuan capsules (granules), Jinlida granules, and other effective drugs for cardiovascular and cerebrovascular diseases, respiratory diseases, and diabetes. Take benefits.

In the past two years, Lianhua Qing Plague has played an important role in the global epidemic prevention and control work. As of now, it has been approved to be listed in nearly 30 countries and regions around the world. Approval of new crown pneumonia in Kuwait, Laos and other countries; selected for the whitening of anti -epidemic drugs released by the Ministry of Health of Uzbekistan; approved to enter the designated hospital in Thailand and Cambodia's new crown pneumonia, and was selected as home treatment plan released by the Ministry of Health. , For the first time in Chinese drugs, the treatment of new crown pneumonia in overseas countries.

Tongxinluo Capsules, Yangzheng Capital Capsules and other varieties have been registered and sold in countries such as South Korea, Vietnam, Canada, Singapore, Indonesia and other countries.

Cover three types of Tongluo Capsules, Ginseng Yangxin Capsules, and Qiqiang Qiangxin Capsule, which is studied after the listing of "TCM Period Theory Construction and Guiding Micro Vehicle Lessic Prevention" project, which won the first prize of national science and technology progress in 2019. This is the only first national scientific and technological progress prize in the field of medical and health in my country. The award proves the clinical efficacy of Tongluo drugs in the prevention and control of cardiovascular and cerebrovascular diseases, and also explains the charm of combining Chinese medicine and modern technology. The research project clarifies that the common mechanism of the incurable diseases such as cardiovascular and cerebrovascular diseases and diabetic nephropathy that seriously endangers human health is microvascular lesions, and the protection of microvascular endothelial cells is the core mechanism for the treatment of microvascular lesions. The group agreed that the project was "a major breakthrough in Chinese medicine for the treatment of microvascular lesions." The project uses internationally recognized evidence -based medical research methods to carry out a large number of clinical trials to solve major problems in the international medical community -Tongxinluo Capsule solves the problem of acute myocardial infarction without reinstatement; The accompanying premature battle treatment provides new drugs, which fills the gap in the treatment of sinus heart -to -heart movement and slowing down, premature battle, fasting, and integrated tuning. The National 973 Planning Project Acceptance Expert Group claims that this study "created 'theory+clinical+new medicine+experiment+evidence -based" integrated Chinese medicine academic innovation and transformation model, the combination of traditional Chinese medicine theoretical innovation and modern science and technology, produced majority Original results have been demonstrated for the inheritance and innovation development of traditional Chinese medicine. "

The conference conducted in -depth exchanges on a series of innovative achievements in the theoretical research and obtained of linked disease, and provided new perspectives and new ideas for theoretical innovation of Chinese medicine. Inherit the essence and keep innovation. In the future, the transformation of the research and a series of innovative achievements of Chinese medicine neat disease will definitely promote the development of Chinese medicine to a new era.

- END -